Literature DB >> 36102658

Prostaglandin E2-Induced Immune Suppression via Cytotoxic T-Lymphocyte Antigen 4 in Paratuberculosis.

Yamato Sajiki1, Satoru Konnai1,2, Kei Watari1, Tomohiro Okagawa2, Akina Tanaka1, Satoko Kawaji3, Reiko Nagata3, Naoya Maekawa2, Yasuhiko Suzuki2,4, Yukinari Kato5,6, Shiro Murata1,2, Yasuyuki Mori3, Kazuhiko Ohashi1,2.   

Abstract

Paratuberculosis is a chronic enteritis of ruminants caused by the facultative intracellular pathogen Mycobacterium avium subsp. paratuberculosis. The Th1 response inhibits the proliferation of M. avium subsp. paratuberculosis during the early subclinical stage. However, we have previously shown that immune inhibitory molecules, such as prostaglandin E2 (PGE2), suppress M. avium subsp. paratuberculosis-specific Th1 responses as the disease progresses. To date, the mechanism underlying immunosuppression during M. avium subsp. paratuberculosis infection has not been elucidated. Therefore, in the present study, we investigated the function of cytotoxic T-lymphocyte antigen 4 (CTLA-4) expressed by peripheral blood mononuclear cells (PBMCs) from cattle with paratuberculosis because CTLA-4 expression is known to be elevated in T cells under an M. avium subsp. paratuberculosis experimental infection. M. avium subsp. paratuberculosis antigen induced CTLA-4 expression in T cells from cattle experimentally infected with M. avium subsp. paratuberculosis. Interestingly, both PGE2 and an E prostanoid 4 agonist also induced CTLA-4 expression in T cells. In addition, a functional assay with a bovine CTLA-4-immunogobulin fusion protein (CTLA-4-Ig) indicated that CTLA-4 inhibited gamma interferon (IFN-γ) production in M. avium subsp. paratuberculosis-stimulated PBMCs, while blockade by anti-bovine CTLA-4 monoclonal antibody increased the secretion of IFN-γ and tumor necrosis factor alpha production in these PBMCs. These preliminary findings show that PGE2 has immunosuppressive effects via CTLA-4 to M. avium subsp. paratuberculosis. Therefore, it is necessary to clarify in the future whether CTLA-4-mediated immunosuppression facilitates disease progression of paratuberculosis in cattle.

Entities:  

Keywords:  CTLA-4; EP4; Johne’s disease; PGE2; cattle

Mesh:

Substances:

Year:  2022        PMID: 36102658      PMCID: PMC9584316          DOI: 10.1128/iai.00210-22

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  38 in total

1.  Bovine Immunoinhibitory Receptors Contribute to Suppression of Mycobacterium avium subsp. paratuberculosis-Specific T-Cell Responses.

Authors:  Tomohiro Okagawa; Satoru Konnai; Asami Nishimori; Ryoyo Ikebuchi; Seiko Mizorogi; Reiko Nagata; Satoko Kawaji; Shogo Tanaka; Yumiko Kagawa; Shiro Murata; Yasuyuki Mori; Kazuhiko Ohashi
Journal:  Infect Immun       Date:  2015-10-19       Impact factor: 3.441

2.  Prostaglandin E2-Induced Immune Exhaustion and Enhancement of Antiviral Effects by Anti-PD-L1 Antibody Combined with COX-2 Inhibitor in Bovine Leukemia Virus Infection.

Authors:  Yamato Sajiki; Satoru Konnai; Tomohiro Okagawa; Asami Nishimori; Naoya Maekawa; Shinya Goto; Kei Watari; Erina Minato; Atsushi Kobayashi; Junko Kohara; Shinji Yamada; Mika K Kaneko; Yukinari Kato; Hirofumi Takahashi; Nobuhiro Terasaki; Akira Takeda; Keiichi Yamamoto; Mikihiro Toda; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Journal:  J Immunol       Date:  2019-07-31       Impact factor: 5.422

Review 3.  Regulatory T cells and immune tolerance.

Authors:  Shimon Sakaguchi; Tomoyuki Yamaguchi; Takashi Nomura; Masahiro Ono
Journal:  Cell       Date:  2008-05-30       Impact factor: 41.582

Review 4.  T cell exhaustion.

Authors:  E John Wherry
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

5.  Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.

Authors:  K Vandenborre; S W Van Gool; A Kasran; J L Ceuppens; M A Boogaerts; P Vandenberghe
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

Review 6.  cAMP during HIV infection: friend or foe?

Authors:  Maria E Moreno-Fernandez; Cesar Mauricio Rueda; Paula A Velilla; Maria Teresa Rugeles; Claire A Chougnet
Journal:  AIDS Res Hum Retroviruses       Date:  2011-11-02       Impact factor: 2.205

7.  Enhanced Immunotherapeutic Efficacy of Anti-PD-L1 Antibody in Combination with an EP4 Antagonist.

Authors:  Yamato Sajiki; Satoru Konnai; Zimeng Cai; Kensuke Takada; Tomohiro Okagawa; Naoya Maekawa; Sotaro Fujisawa; Yukinari Kato; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Journal:  Immunohorizons       Date:  2020-12-21

Review 8.  T-cell regulation by CD28 and CTLA-4.

Authors:  M L Alegre; K A Frauwirth; C B Thompson
Journal:  Nat Rev Immunol       Date:  2001-12       Impact factor: 53.106

Review 9.  EP2 and EP4 prostanoid receptor signaling.

Authors:  John W Regan
Journal:  Life Sci       Date:  2003-12-05       Impact factor: 5.037

10.  Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade.

Authors:  Nobuhiro Nakamoto; Hyosun Cho; Abraham Shaked; Kim Olthoff; Mary E Valiga; Mary Kaminski; Emma Gostick; David A Price; Gordon J Freeman; E John Wherry; Kyong-Mi Chang
Journal:  PLoS Pathog       Date:  2009-02-27       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.